Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan

被引:37
|
作者
Koike, Teruaki
Tsuchiya, Ryosuke
Goya, Tomoyuki
Sohara, Yasunori
Miyaoka, Etsuo
机构
[1] Niigata Canc Ctr Hosp, Div Chest Surg, Japanese Joint Comm Lung Canc Registrat, Niigata 9518566, Japan
[2] Natl Canc Ctr, Div Thorac Surg, Tokyo, Japan
[3] Kyorin Univ, Dept Surg, Mitaka, Tokyo, Japan
[4] Jichi Med Sch, Dept Surg, Minami Kawachi, Tochigi, Japan
[5] Tokyo Univ Sci, Dept Math, Japanese Joint Comm Lung Canc Registrat, Tokyo 162, Japan
关键词
clinical stage I lung cancer; survival; prognostic factor; limited pulmonary resection; maximum tumor diameter;
D O I
10.1097/01.JTO.0000268674.02744.f9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The objective of this retrospective study was to identify prognostic factors in completely resected clinical (c-) stage I non-small cell lung cancer cases. Methods: In 2001, the Japanese Joint Committee of Lung Cancer Registry collected data on the outcome and clinicopathological profiles of 7408 patients who had undergone resection for primary lung cancer in 1994. They included 3315 c-stage I patients who underwent complete resection, and in this study attempted to identify prognostic factors in the c-stage IA and c-stage IB cases. Results: The overall 5-year survival rate was 66.5%: 74.7% in the 2085 c-stage IA cases and 52.5% in the 1230 c-stage IB cases. The survival curve of the c-stage IA cases was higher than that of the c-stage IB cases. Multivariate analysis of the c-stage IA cases revealed six factors that predicted a significantly better outcome: age, gender, pathological (p-) T status, p-N status, nodal dissection, and tumor diameter (: 2 cm), and the same analysis of the c-stage IB cases revealed six factors: age, gender, p-T status, p-N status operative procedure, and tumor diameter (< 5 cm). The c-stage I patients whose tumor diameter was 2 cm or less had a higher survival rate than the patients whose turner diameter was more than 2 cm, and the c-stage IB patients whose tumor diameter was less than 5 cm had a higher survival rate than the patients whose tumor diameter was 5 cm or more. Conclusion: Tumor size is an independent prognostic factor for postoperative survival in c-stage 1 patients.
引用
收藏
页码:408 / 413
页数:6
相关论文
共 50 条
  • [21] Prognostic factors in stage I non-small cell lung cancer - Invited Commentary
    Wittekind, C
    ZENTRALBLATT FUR CHIRURGIE, 1996, 121 (10): : 858 - 860
  • [22] Analysis for prognostic factors of postoperative stage I non-small cell lung cancer
    Park, C
    Park, H
    Keum, D
    Kang, Y
    Han, S
    LUNG CANCER, 2005, 49 : S358 - S358
  • [23] The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer
    Mori, Shunsuke
    Usami, Noriyasu
    Fukumoto, Koichi
    Mizuno, Tetsuya
    Kuroda, Hiroaki
    Sakakura, Noriaki
    Yokoi, Kohei
    Sakao, Yukinori
    PLOS ONE, 2015, 10 (09):
  • [24] Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Nakata, M.
    Nojima, Y.
    Nanba, K.
    Saisho, S.
    Shimizu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S845 - S846
  • [25] Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer
    Naim Younes, R.
    Gross, J. L.
    Abrao, F. C.
    Rodrigues Pereira, J.
    MINERVA CHIRURGICA, 2013, 68 (02) : 169 - 174
  • [26] Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
    Liang, Ying
    Wakelee, Heather A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 403 - 410
  • [27] Tumor Location Is an Independent Prognostic Factor in Completely Resected Pathological Stage I Non-Small Cell Lung Cancer: A Multicenter Retrospective Study
    Kuo, Wei-Ke
    Chen, Po-Ju
    Wu, Mei-Hsuan
    Lee, Hsin-Chung
    Fan, Jiun-Kai
    Hsu, Pang-Hung
    Weng, Ching-Fu
    CANCERS, 2024, 16 (09)
  • [28] Efficacy of Adjuvant Chemotherapy for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Byun, M. K.
    Park, H. J.
    Park, H. S.
    Jeung, H.
    Cho, J. Y.
    Lee, S. S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1982 - S1982
  • [29] Prognostic value of immunohistochemical stain pattern for carcinoembryonic antigen in patients with completely resected pathological stage I non-small cell lung cancer
    Suzuki, H.
    Matsuguma, H.
    Igarashi, S.
    Nakahara, R.
    Ohata, N.
    Kasai, T.
    Kmiyama, Y.
    Mori, M.
    Kodama, T.
    Yokoi, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 514 - 514
  • [30] Selection for adjuvant chemotherapy in completely resected stage I non-small cell lung cancer: external validation of a Chinese prognostic risk model
    Kumbasar, Ulas
    Raubenheimer, Hilgardt
    Al Sahaf, May
    Asadi, Nizar
    Cufari, Maria Elena
    Proli, Chiara
    Perikleous, Periklis
    Niwaz, Zakiyah
    Beddow, Emma
    Anikin, Vladimir
    McGonigle, Niall
    Jordan, Simon
    Ladas, George
    Dusmet, Michael
    Lim, Eric
    JOURNAL OF THORACIC DISEASE, 2016, 8 (01) : 140 - 144